Deng Y, Tarassishin L, Kallhoff V, Peethumnongsin E, Wu L, Li YM, Zheng H.
Deletion of presenilin 1 hydrophilic loop sequence leads to impaired gamma-secretase activity and exacerbated amyloid pathology.
J Neurosci. 2006 Apr 5;26(14):3845-54.
PubMed.
This is a very interesting paper. It indicates that loss of PS1 function may lead to plaque pathology and amyloid depositions. The authors conclude that it is the loss of the γ-secretase function of PS1 and the reduction of Aβ1-40 that lead to increased plaque pathology. Although this conclusion is in agreement with several reports in the last years that presenilin FAD mutations cause a loss (rather than a gain) of γ-secretase function, it is not necessary that the mechanism of plaque pathology in AD involves directly the γ-secretase function. Increased plaque pathology (and even Aβ production) may also result from increased activities in apoptotic pathways that, in turn, may be caused by many factors including a loss of PS1 function in cell survival pathways, a γ-secretase-independent function of PS1 (Baki et al., 2004).
References:
Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK.
PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.
EMBO J. 2004 Jul 7;23(13):2586-96.
PubMed.
Comments
Mount Sinai School of Medicine, NYU
This is a very interesting paper. It indicates that loss of PS1 function may lead to plaque pathology and amyloid depositions. The authors conclude that it is the loss of the γ-secretase function of PS1 and the reduction of Aβ1-40 that lead to increased plaque pathology. Although this conclusion is in agreement with several reports in the last years that presenilin FAD mutations cause a loss (rather than a gain) of γ-secretase function, it is not necessary that the mechanism of plaque pathology in AD involves directly the γ-secretase function. Increased plaque pathology (and even Aβ production) may also result from increased activities in apoptotic pathways that, in turn, may be caused by many factors including a loss of PS1 function in cell survival pathways, a γ-secretase-independent function of PS1 (Baki et al., 2004).
References:
Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 2004 Jul 7;23(13):2586-96. PubMed.
Make a Comment
To make a comment you must login or register.